Scientists have developed glucose-sensitive probiotic bacteria capable of adapting in the gut to manage diabetes, potentially offering an oral alternative to injections and implants. Engineered probiotic bacteria may one day offer a way to manage diabetes from the gut rather…
Emerging studies reveal that the enzyme cathepsin D may interfere with insulin signalling in the liver, potentially contributing to prediabetes and offering new avenues for treatment. A protein best known for helping cells break down waste may also be interfering…
Florida State University’s health and nursing teams are opening enrolment for LEADR, a pioneering 12-week programme combining group support, personalised coaching, and lifestyle interventions to help individuals with prediabetes and type 2 diabetes improve health and potentially achieve remission. Florida…
The landmark Look AHEAD trial reveals that despite achieving short-term weight loss and metabolic improvements, intensive lifestyle interventions do not necessarily translate into lowered cardiovascular events among adults with type 2 diabetes, challenging assumptions about weight reduction as a primary…
Pharmaceutical giant Eli Lilly has launched its first lawsuits against six US companies, aiming to curb illegal sales of its unapproved weight-loss and diabetes treatment, retatrutide, amid growing risks to consumer safety. Eli Lilly has begun legal action against six…
Sami Inkinen’s shift from tech to medicine led to Virta Health’s pioneering approach, combining nutrition science, remote monitoring, and personalised coaching to transform diabetes management and challenge traditional care models. Sami Inkinen built a career in technology before turning his…
Once primarily used for blood sugar management, GLP-1 receptor agonists are now recognised for their broader role in protecting the heart, kidneys, and even sleep health, transforming long-term care strategies for patients with type 2 diabetes and obesity. GLP-1 medicines…
A large observational study suggests that GLP-1 receptor agonists may offer protective benefits against fragility fractures in older adults with type 2 diabetes, raising hopes for broader skeletal health effects beyond glucose regulation. A large observational study has added to…
A Bahrain-backed charity has donated insulin pumps to ten children with diabetes, emphasising social solidarity and improving disease management with advanced technology. Ten children with diabetes have received insulin pumps in a Bahrain-backed charity initiative aimed at easing the daily…
Breakthrough T1D announces its 2026-27 run season, leveraging major international races to boost awareness and funding for type 1 diabetes research, including innovative support options like the ‘My Run’ programme. Breakthrough T1D has launched its 2026-27 run season, using a…
